Literature DB >> 30503887

A neonatal mouse model of Enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis.

Shiyang Sun1, Lianlian Bian2, Fan Gao3, Ruixiao Du4, Yalin Hu5, Ying Fu6, Yao Su7, Xing Wu8, Qunying Mao9, Zhenglun Liang10.   

Abstract

Enterovirus D68 (EV-D68) is a causative agent of recent outbreaks of severe respiratory illness, pneumonia and acute flaccid myelitis (AFM) worldwide. The study of the pathogenesis, vaccines and anti-viral drugs for EV-D68 infection has been reported. Given the previously described mouse model of EV-D68, we sought to establish a neonatal mice model inducing both pneumonia and AFM. The neonatal BALB/c mice were inoculated intraperitoneally with the EV-D68 strain (named15296-virus) which was produced by the reverse genetics method. The infected mice displayed limb paralysis, tachypnea and even death, which were similar to the clinical symptoms of human infections. Moreover, the results of histopathologic examination and immunohistochemical staining showed acidophilic necrosis in the muscle, the spinal cord and alveolar wall thickening in the lung, indicating that EV-D68 exhibited strong tropism to the muscles, spinal cord and lung. Furthermore, the results of real-time PCR also suggested that the viral loads in the blood, spinal cord, muscles and lung were higher than those in other tissues at different time points post-infection. Additionally, the neonatal mouse model was used for evaluating the EV-D68 infection. The results of the anti-serum passive and maternal antibody protection indicated that the neonatal mice could be protected against the EV-D68 challenge, and displayed that both the serum of 15296-virus and prototype-virus (Fermon) were performing a certain cross-protective activity against the 15296-virus challenge. In summary, the above results proved that our neonatal mouse model possessed not only the interstitial pneumonia and AFM simultaneously but also a potentiality to evaluate the protective effects of EV-D68 vaccines and anti-viral drugs in the future.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Acute flaccid myelitis; Enterovirus D68; Infection; Interstitial pneumonia; Neonatal mouse model

Mesh:

Substances:

Year:  2018        PMID: 30503887     DOI: 10.1016/j.antiviral.2018.11.013

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  14 in total

1.  Enterovirus D68 Antivirals: Past, Present, and Future.

Authors:  Yanmei Hu; Rami Musharrafieh; Madeleine Zheng; Jun Wang
Journal:  ACS Infect Dis       Date:  2020-05-14       Impact factor: 5.084

2.  Contemporary Circulating Enterovirus D68 Strains Infect and Undergo Retrograde Axonal Transport in Spinal Motor Neurons Independent of Sialic Acid.

Authors:  Alison M Hixon; Penny Clarke; Kenneth L Tyler
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

3.  Bioinformatics Analysis of Gut Microbiota and CNS Transcriptome in Virus-Induced Acute Myelitis and Chronic Inflammatory Demyelination; Potential Association of Distinct Bacteria With CNS IgA Upregulation.

Authors:  Seiichi Omura; Fumitaka Sato; Ah-Mee Park; Mitsugu Fujita; Sundar Khadka; Yumina Nakamura; Aoshi Katsuki; Kazuto Nishio; Felicity N E Gavins; Ikuo Tsunoda
Journal:  Front Immunol       Date:  2020-07-07       Impact factor: 7.561

Review 4.  Acute flaccid myelitis: cause, diagnosis, and management.

Authors:  Olwen C Murphy; Kevin Messacar; Leslie Benson; Riley Bove; Jessica L Carpenter; Thomas Crawford; Janet Dean; Roberta DeBiasi; Jay Desai; Matthew J Elrick; Raquel Farias-Moeller; Grace Y Gombolay; Benjamin Greenberg; Matthew Harmelink; Sue Hong; Sarah E Hopkins; Joyce Oleszek; Catherine Otten; Cristina L Sadowsky; Teri L Schreiner; Kiran T Thakur; Keith Van Haren; Carolina M Carballo; Pin Fee Chong; Amary Fall; Vykuntaraju K Gowda; Jelte Helfferich; Ryutaro Kira; Ming Lim; Eduardo L Lopez; Elizabeth M Wells; E Ann Yeh; Carlos A Pardo
Journal:  Lancet       Date:  2020-12-23       Impact factor: 79.321

5.  Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.

Authors:  Nischay Mishra; Terry Fei Fan Ng; M Steven Oberste; W Ian Lipkin; Rachel L Marine; Komal Jain; James Ng; Riddhi Thakkar; Adrian Caciula; Adam Price; Joel A Garcia; Jane C Burns; Kiran T Thakur; Kimbell L Hetzler; Janell A Routh; Jennifer L Konopka-Anstadt; W Allan Nix; Rafal Tokarz; Thomas Briese
Journal:  mBio       Date:  2019-08-13       Impact factor: 7.867

Review 6.  Understanding Enterovirus D68-Induced Neurologic Disease: A Basic Science Review.

Authors:  Alison M Hixon; Joshua Frost; Michael J Rudy; Kevin Messacar; Penny Clarke; Kenneth L Tyler
Journal:  Viruses       Date:  2019-09-04       Impact factor: 5.048

Review 7.  Current Understanding of Human Enterovirus D68.

Authors:  Jing Sun; Xiao-Yi Hu; Xiao-Fang Yu
Journal:  Viruses       Date:  2019-05-29       Impact factor: 5.048

Review 8.  Molecular Pathogenicity of Enteroviruses Causing Neurological Disease.

Authors:  Anna Majer; Alan McGreevy; Timothy F Booth
Journal:  Front Microbiol       Date:  2020-04-09       Impact factor: 5.640

9.  Mapping Attenuation Determinants in Enterovirus-D68.

Authors:  Ming Te Yeh; Sara Capponi; Adam Catching; Simone Bianco; Raul Andino
Journal:  Viruses       Date:  2020-08-08       Impact factor: 5.048

10.  Enterovirus D68-Associated Acute Flaccid Myelitis, United States, 2020.

Authors:  Sarah Kidd; Adriana S Lopez; Jennifer L Konopka-Anstadt; W Allan Nix; Janell A Routh; M Steven Oberste
Journal:  Emerg Infect Dis       Date:  2020-08-24       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.